Neuropsychiatric complications of COVID-19
ZM Nakamura, RP Nash, SL Laughon… - Current psychiatry …, 2021 - Springer
Abstract Purpose of Review To describe the presentation, etiologies, and suggested
management of post-acute COVID-19 neuropsychiatric symptoms. Recent Findings Over …
management of post-acute COVID-19 neuropsychiatric symptoms. Recent Findings Over …
The SARS-CoV-2 and mental health: From biological mechanisms to social consequences
D Szcześniak, A Gładka, B Misiak, A Cyran… - Progress in Neuro …, 2021 - Elsevier
In December 2019, the first case of severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2, COVID-19) infection was reported. In only few weeks it has caused a global …
CoV-2, COVID-19) infection was reported. In only few weeks it has caused a global …
Prevalence and predictors of posttraumatic stress disorder, depression and anxiety among hospitalized patients with coronavirus disease 2019 in China
Y Chen, X Huang, C Zhang, Y An, Y Liang, Y Yang… - BMC psychiatry, 2021 - Springer
Abstract Background Coronavirus disease 2019 (COVID-19) has affected more than 5
million people around the world and killed more than 300,000 people; thus, it has become a …
million people around the world and killed more than 300,000 people; thus, it has become a …
Adverse drug reactions in SARS-CoV-2 hospitalised patients: a case-series with a focus on drug–drug interactions
G Crescioli, V Brilli, C Lanzi, A Burgalassi, A Ieri… - Internal and Emergency …, 2021 - Springer
Due to the need of early and emergency effective treatments for COVID-19, less attention
may have been paid to their safety during the global emergency. In addition, characteristics …
may have been paid to their safety during the global emergency. In addition, characteristics …
Safety management in treatment with antimalarials in rheumatology. Interdisciplinary recommendations on the basis of a systematic literature review.
C Fiehn, T Ness, C Weseloh… - Zeitschrift für …, 2021 - search.ebscohost.com
The online version of this article (https://doi. org/10.1007/s00393-020-00785-4) contains
further information on systematic literature searches. Article and supplementary material are …
further information on systematic literature searches. Article and supplementary material are …
Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort study
Objectives Concern has been raised in the rheumatology community regarding recent
regulatory warnings that HCQ used in the coronavirus disease 2019 pandemic could cause …
regulatory warnings that HCQ used in the coronavirus disease 2019 pandemic could cause …
Psychiatric clinical profiles and pharmacological interactions in COVID-19 inpatients referred to a consultation liaison psychiatry unit: a cross-sectional study
N Arbelo, H López-Pelayo, M Sagué, S Madero… - Psychiatric …, 2021 - Springer
Abstract The Coronavirus Disease 2019 (COVID-19) can affect mental health in different
ways. There is little research about psychiatric complications in hospitalized patients with …
ways. There is little research about psychiatric complications in hospitalized patients with …
Pharmacological agents under investigation in the treatment of coronavirus disease 2019 and the importance of melatonin
Abstract Coronavirus disease 2019 (COVID‐19) is a life‐threatening infectious respiratory
disease caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) …
disease caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) …
Association of antimalarial drugs with decreased overall and cause specific mortality in systemic lupus erythematosus
Z Jin, F Wang, W Pan, L Liu, M Wu, H Hu, X Ding… - …, 2021 - academic.oup.com
Objective To evaluate the association and dose–response pattern between antimalarial
drugs and overall and cause specific mortality in SLE patients. Methods Medical records …
drugs and overall and cause specific mortality in SLE patients. Methods Medical records …
Evaluation of IGF-1 as a novel theranostic biomarker for schizophrenia
Objective In the current study, we aimed to investigate fasting plasma levels of glucose,
insulin, growth hormone, IGF-1, and lipid profile in remission schizophrenia patients …
insulin, growth hormone, IGF-1, and lipid profile in remission schizophrenia patients …